Trial of Gemcitabine, Carboplatin, and Sorafenib in Chemotherapy-naive Patients With Advanced/Metastatic Bladder Carcinoma

NCT00461851 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Bladder Cancer

Interventions

DRUG: Gemcitabine
DRUG: Carboplatin
DRUG: Sorafenib

Sponsor

Yale University

Collaborators

[object Object]